Timeline Staleness Signal

Decitabine (DTC Arm)

Decitabine (DTC Arm) is flagged as timeline staleness signal because public records show timeline staleness, operational burden. This is a public-data monitoring signal, not a conclusion about clinical failure, regulatory noncompliance, or sponsor intent.

Program overview

Context

Indication: Primary Malignant Neoplasm of Ovary

Mechanism: Unknown

Modality: Unknown

Sponsor: Chinese PLA General Hospital

Scores

Risk-signal summary

Registry: 3/5

Timeline: 3/5

Recruitment burden: 2/5

Results availability: 0/5

Program risk: 4/5

Evidence

Public links

https://clinicaltrials.gov/study/NCT02159820

Linked trials

Trial-level signal details

TrialStatusTimelineResultsBurden
NCT02159820Unknown Status Signal (UNKNOWN)stale_update_signal | primary_completion_date_past_signal | completion_date_past_signalLow Signallarge_enrollment_target_signal | few_sites_large_trial_signal